The Effects of Histone Deacetylase Inhibitors on Glioblastoma-Derived Stem Cells

Journal of Molecular Neuroscience

Volumn 55, Issue 1, 2015, Pages 7-20

  Alvarez, Angel A ^a   Field, Melvin ^a   Bushnev, Sergey ^a   Longo, Matthew S ^a   Sugaya, Kiminobu ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Cancer stem cells; Glioblastoma multiforme; Histone deactylation; Trichostatin A

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; TRICHOSTATIN A; VALPROIC ACID;

CANCER STEM CELL; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; NEUROGENESIS; VALPROIC ACID;

EID: 84929581428     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0329-0     Document Type: Article

References (89)

1. Aerts JL, Gonzales MI, Topalian SL (2004) Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR. BioTech 36(1):84-86, 88, 90-81.
2. Aguado T, Carracedo A, Julien B, Velasco G, Milman G, Mechoulam R, Alvarez L, Guzman M, Galve-Roperh I (2007) Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J Biol Chem 282(9):6854–6862
3. Annabi B, Lachambre MP, Plouffe K, Sartelet H, Beliveau R (2009a) Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinog 48(10):910–919
4. Annabi B, Laflamme C, Sina A, Lachambre MP, Beliveau R (2009b) A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells. J Neuroinflammation 6:8
5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756–760
6. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U, Beier CP (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67(9):4010–4015
7. Besser D (2004) Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279(43):45076–45084
8. Bigner DD, Bigner SH, Ponten J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ (1981) Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40(3):201–229
9. Brannen CL, Sugaya K (2000) In vitro differentiation of multipotent human neural progenitors in serum-free medium. Neuroreport 11(5):1123–1128
10. Breier JM, Radio NM, Mundy WR, Shafer TJ (2008) Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol Sci 105(1):119–133
11. Chambers I, Colby D, Robertson M et al (2003) Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643–655
12. Chuang H, Chen C et al (2011) Reduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma. Exp Therapuetic Med 2(1):63–67
13. Cikos S, Bukovska A, Koppel J (2007) Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol 8:113
14. Das A, Banik NL, Ray SK (2008) Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neuro-Oncol 87(1):9–22
15. De Witt Hamer PC, Van Tilborg AA, Eijk PP, Sminia P, Troost D, Van Noorden CJ, Ylstra B, Leenstra S (2008) The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 27(14):2091–2096
16. Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD (2007) Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci 8:36
17. Estes ML, Ransohoff RM, McMahon JT, Jacobs BS, Barna BP (1990) Characterization of adult human astrocytes derived from explant culture. J Neurosci Res 27(4):697–705
18. Field M, Alvarez A, Bushnev S, Sugaya K (2010) Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients. Clin Neurosurg 57:151–159 [serial online]
19. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71(8):2585–2597
20. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A (2004a) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64(19):7011–7021
21. Galli R, Binda E, Orfanelli U (2004b) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011–7021
22. Gerard CJ, Olsson K, Ramanathan R, Reading C, Hanania EG (1998) Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res 58(17):3957–3964
23. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27(20):2897–2909
24. Guthrie GD, Eljamel S (2013) Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme. J Neurosurg 118(4):859–865
25. Hemmati HD, Nakano I, Lazareff JA et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100:15178–15183
26. Huggett J, Dheda K, Bustin S, Zumla A (2005) Real-time RT-PCR normalisation; strategies and considerations. Genes Immun 6(4):279–284
27. Huncharek M, Muscat J (1998) Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients. Anticancer Res 18(2B):1303–1311
28. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol (Zurich, Switzerland) 9(3):469–479
29. Jeanmougin M, de Reynies A, Marisa L, Paccard C, Nuel G, Guedj M (2010) Should we abandon the t-test in the analysis of gene expression microarray data: a comparison of variance modeling strategies. PLoS ONE 5(9):e12336
30. Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355(12):1253–1261
31. Kang MK, Hur BI, Ko MH, Kim CH, Cha SH, Kang SK (2008) Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci 9:15
32. Kim J, Chu J, Shen X et al (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132:1049–1061
33. Kim JB, Sebastiano V, Wu GM et al (2009) Oct4-induced pluripotency in adult neural stem cells. Cell 136:411–419
34. Kwak YD, Brannen CL, Qu T, Kim HM, Dong X, Soba P, Majumdar A, Kaplan A, Beyreuther K, Sugaya K (2006a) Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev 15(3):381–389
35. Kwak YD, Choumkina E, Sugaya K (2006b) Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells. Biochem Biophys Res Commun 344(1):431–437
36. La Torre D, de Divitiis O, Conti A, Angileri FF, Cardali S, Aguennouz M, Aragona M, Panetta S, DAvella D, Vita G et al (2005) Expression of telomeric repeat binding factor-1 in astroglial brain tumors. Neurosurgery 56(4):802–810
37. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190–198
38. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A et al (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99(3):467–473
39. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5):391–403
40. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
41. Liu Q et al (2009) Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neuro-Oncol 94(1):1–19
42. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, California) 25(4):402–408
43. Loo DT, Althoen MC, Cotman CW (1995) Differentiation of serum-free mouse embryo cells into astrocytes is accompanied by induction of glutamine synthetase activity. J Neurosci Res 42(2):184–191
44. Lopez CA, Feng FY, Herman JM, Nyati MK, Lawrence TS, Ljungman M (2007) Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation. Int J Radiat Oncol Biol Phys 69(1):214–220
45. Marchal-Victorion S, Deleyrolle L, De Weille J, Saunier M, Dromard C, Sandillon F, Privat A, Hugnot JP (2003) The human NTERA2 neural cell line generates neurons on growth under neural stem cell conditions and exhibits characteristics of radial glial cells. Mol Cell Neurosci 24(1):198–213
46. Masoudi A et al (2008) Influence of valporic acid on outcome of high-grade gliomas in children. Anticancer Res 28(4C):2437–2442
47. McKeever PE, Hood TW, Varani J, Taren JA, Beierwaltes WH, Wahl R, Liebert M, Nguyen PK (1987) Products of cells cultured from gliomas. V. Cytology and morphometry of two cell types cultured from glioma. J Natl Cancer Inst 78(1):75–84
48. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC et al (2008) Stem cell-related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26(18):3015–3024
49. Nakai E, Park K, Yawata T, Chihara T, Kumazawa A, Nakabayashi H, Shimizu K (2009) Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma. Cancer Investig:1
50. Pfenninger CV, Roschupkina T, Hertwig F, Kottwitz D, Englund E, Bengzon J, Jacobsen SE, Nuber UA (2007) CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res 67(12):5727–5736
51. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ (2008) Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A 105(11):4329–4334
52. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, Qi Q, Lu N, Tao L, Wang XT et al (2009): Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer lett
53. Rich JN (2007) Cancer stem cells in radiation resistance. Cancer Res 67(19):8980–8984
54. Rieu I, Powers SJ (2009) Real-time quantitative RT-PCR: design, calculations, and statistics. Plant Cell 21(4):1031–1033
55. Rutka JT, Giblin JR, Dougherty DY, Liu HC, McCulloch JR, Bell CW, Stern RS, Wilson CB, Rosenblum ML (1987) Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 75(1):92–103
56. Rychlik W (2007) OLIGO 7 primer analysis software. Methods in molecular biology (Clifton, NJ) 402:35–60
57. Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C, Ciusani E, Sciacca FL, Ottolina A, Parati EA, La Porta C et al (2006) Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54(8):850–860
58. Schmittgen TD, Zakrajsek BA (2000) Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 46(1–2):69–81
59. Shervington A, Lu C (2008) Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Investig 26(5):535–542
60. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26(2):239–244
61. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821–5828
62. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004a) Identification of human brain tumour initiating cells. Nature 432(7015):396–401
63. Singh SK, Clarke ID, Hide T, Dirks PB (2004b) Cancer stem cells in nervous system tumors. Oncogene 23(43):7267–7273
64. Singh SK, Hawkins C, Clarke ID et al (2004c) Identification of human brain tumour initiating cells. Nature 432:396–401
65. Smith JR, Vallier L, Lupo G, Alexander M, Harris WA, Pedersen RA (2008) Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol 313(1):107–117
66. Student (1908) The probable error of a mean. Biometrika, 6(1):1-25.
67. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R et al (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20(5):1375–1382
68. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996
69. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA (1998) A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 85(2):141–152
70. Tabibzadeh S, Hemmati-Brivanlou A (2006) Lefty at the crossroads of “stemness” and differentiative events. Stem Cells (Dayton, Ohio) 24(9):1998–2006
71. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S, Tanino M, Nishihara H, Tanaka S (2008) Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 18(10):1037–1046
72. Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC (2007) Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg 21(5):496–500
73. Tsai HC et al (2012) Effect of valproic acid on the outcome of glioblastoma multiforme. Br J Neurosurg 26(3):347–354
74. van den Bent MJ, Hegi ME, Stupp R (2006) Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer 42(5):582–588
75. Vlassenbroeck I, Califice S, Diserens AC, Migliavacca E, Straub J, Di Stefano I, Moreau F, Hamou MF, Renard I, Delorenzi M et al (2008) Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma. J Mol Diagn 10(4):332–337
76. Vrotsos EG, Sugaya K (2009) MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling. Cell Mol Neurobiol 29(3):373–381
77. Vrotsos EG, Kolattukudy PE, Sugaya K (2009) MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling. Brain Res Bull 79(2):97–103
78. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5(10):1725–1731
79. Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H (2007) Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization. Cell Mol Neurobiol 27(7):831–843
80. Wang K, Chen Y et al (2009) Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.Cloning. Stem Cells 11(4):483–496
81. Welch BL (1938) The significance of the difference between two means when the population variances are unequal. Biometrika 29(3/4):350–362
82. Welch BL (1947) The generalization of “Student’s” problem when several different population variances are involved. Biometrika 34(1/2):28–35
83. Yao XH, Ping YF, Chen JH, Xu CP, Chen DL, Zhang R, Wang JM, Bian XW (2008) Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J Pathol 215(4):369–376
84. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, Gao L, Wang JM, Bian XW (2008) Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265(1):124–134
85. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL, Yu JS (2004a) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23(58):9392–9400
86. Yuan X, Curtin J, Xiong Y et al (2004b) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392–9400
87. Yuan JS, Reed A, Chen F, Stewart CN Jr (2006) Statistical analysis of real-time PCR data. BMC Bioinforma 7:85
88. Zhang QB, Ji XY, Huang Q, Dong J, Zhu YD, Lan Q (2006) Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells. Cell Res 16(12):909–915
89. Zimmerman DW (2004) A note on preliminary tests of equality of variances. Br J Math Stat Psychol 57(Pt 1):173–181